The Early Diagnosis and Detection (ED&D) Centre at The Royal Marsden and the Institute of Cancer Research (ICR) is a leading research facility dedicated to cancer early diagnosis and detection programmes. Our mission is:
To achieve the early diagnosis priorities of the NHS England Long Term Plan by excelling in risk stratified early detection research, clinical translation of early detection technologies, and collaborative research through local, national, and international partnerships.
The ED&D Centre combines world-class expertise in genetics, liquid biopsy and artificial intelligence based research, as well as promoting the use of liquid biopsy based research. There are several collaborative research projects in prostate, lung, head & neck, molecular biology and bioinformatics.
These initiatives have extensive links to The Royal Marsden and the ICR, as well as our collaborators across the UK and internationally. The ED&D centre will aim to form direct access for translation of early cancer detection research into clinical trials and practice.
The ED&D centre is a new centre and was officially launched on 10 September 2021 after engagements with various stakeholders over two years. Founded by Dr. Richard Lee, Prof. Ros Eeles and Prof. Stan Kaye, the centre benefits from links with: Royal Marsden Partners, the National Institute for Health Research (NIHR) Biomedical Research Centre at The Royal Marsden and the ICR, The Royal Marsden Cancer Charity, Applied Health Sciences Collaborators, and the NIHR Oncology Translational Research Collaboration.